Delivery Order SPE2DR25D3201-SPE2DR26FT5NT
Award Date 1/21/26
Potential Completion Date 1/22/26
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,274.00 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Quviviq 50 mg tablets (30-count). This firm fixed price delivery order, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a $2,274.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Quviviq 50 mg on November 25, 2025, with an ultimate completion date of November 26, 2025. The award is unclassified with no set-aside designation and represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,212.55 for Quiviviq 25 mg tablets (30-count packages) on September 25, 2025, with an ultimate completion date of September 26, 2025. This is a firm fixed-price, non-set-aside contract to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. This...
- The Defense Logistics Agency awarded a $1,356.74 delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Quviviq 25 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania, and a completion deadline of December 1, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,611.45 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Quviviq 25 mg tablets (30-count). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and requires completion by September 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical federal medical procurement vendor, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,367.56 to AmerisourceBergen Drug Corp for QUVIVIQ 25 mg tablets (30-count supply) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of the vendor's established pharmaceutical supply relationship with the federal government. The product will be delivered to the place of performance in...
- The Defense Logistics Agency (DLA) awarded a $2,712.98 delivery order to AmerisourceBergen Drug Corp for QUVIVIQ 25 mg tablets (30-count supply) on December 17, 2025, with an ultimate completion date of December 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $1,850.10 delivery order to AmerisourceBergen Drug Corp for QUVIVIQ 50mg tablets (30-count) under a firm fixed price contract type. The award was made on December 19, 2025, with an ultimate completion date of December 22, 2025. This is an unset-aside, competitively awarded delivery order that represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at...
- The Defense Logistics Agency awarded a $1,233.40 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of QUVIVIQ 50MG tablets (30-count packaging). This is a firm fixed-price delivery order with an ultimate completion date of December 16, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under...
- The Defense Logistics Agency awarded a $1,614.22 delivery order to AmerisourceBergen Drug Corp for QUVIVIQ 50 mg tablets (30-count supply) on September 19, 2025, with completion targeted for September 22, 2025. This firm fixed-price delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside designation and was competitively...